Evidence map›Paper›PMID 38414955›Full record

ArticleEcancermedicalscience2023

Biochemical outcome after curative treatment for localized prostate cancer with external beam radiotherapy: a cross-sectional study.

Joseph Daniels, Kofi Adesi Kyei, Kikelomo Adeola Badejoko-Okunade, Samuel Anim-Sampong, Samuel Nii Adu Tagoe, William Kwadwo Antwi, Joana Ainuson-Quampah, Adewumi Alabi, Anthonia Sowunmi, Judith Naa Odey Tackie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ecancermedicalscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Joseph DanielsNational Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, PO Box KB 369, Korle Bu, Accra, Ghana.
Kofi Adesi KyeiNational Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, PO Box KB 369, Korle Bu, Accra, Ghana.
Kikelomo Adeola Badejoko-OkunadeDepartment of Radiography, University of Ghana, Legon, PO Box KB 143, Korle Bu, Accra, Ghana.
Samuel Anim-SampongDepartment of Radiography, University of Ghana, Legon, PO Box KB 143, Korle Bu, Accra, Ghana.
Samuel Nii Adu TagoeDepartment of Radiography, University of Ghana, Legon, PO Box KB 143, Korle Bu, Accra, Ghana.
William Kwadwo AntwiDepartment of Radiography, University of Ghana, Legon, PO Box KB 143, Korle Bu, Accra, Ghana.
Joana Ainuson-QuampahDepartment of Dietetics, University of Ghana, Legon, PO Box KB 143, Korle Bu, Accra, Ghana.
Adewumi AlabiLagos University Teaching Hospital, Ishaga Road, PO Box 102215, Lagos, Nigeria.
Anthonia SowunmiLagos University Teaching Hospital, Ishaga Road, PO Box 102215, Lagos, Nigeria.
Judith Naa Odey TackieNational Centre for Radiotherapy, Oncology and Nuclear Medicine, Korle Bu Teaching Hospital, PO Box KB 369, Korle Bu, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although many patients who receive definitive radiotherapy (RT) for localised prostate cancer (CaP) experience long-term disease-free survival and better quality of life, some also have biochemical progression during follow-up. Oftentimes this implies additional treatment for patients with the accompanying challenges of cumulative treatment side effects, inconvenience and financial toxicity. This study retrospectively assessed the clinicopathological characteristics and biochemical outcomes of patients treated for localised CaP with external beam radiotherapy (EBRT) between 2015 and 2020 at a major cancer treatment centre in Accra, Ghana. Patients' socio-demographic and clinical data were collected from their hospital records and analysed with the Statistical Package for Social Sciences version 26. Biochemical failure (BCF) was defined as an increase in the level of serum prostate-specific antigen (PSA) >2 ng/mL above the nadir after curative therapy based on the Phoenix definition. The mean age was 67.6 years (SD ± 6.2). The majority of the study participants (

Indexed as

androgen deprivation therapybiochemical recurrenceexternal beam radiotherapyintensity-modulated radiotherapylocalised prostate cancerprostate adenocarcinomaprostate-specific antigenradiotherapytime to biochemical progression

Identifiers

PMID38414955
PMCPMC10898902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.